[2] S. Richardson, J.S. Hirsch, M. Narasimhan, J.M. Crawford, T. McGinn,
K.W. Davidson, et al., Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area, JAMA
22 (2020) e206775, ,
https://doi.org/10.1001/jama.2020.6775.[5] J. Yang, Y. Zheng, X. Gou, K. Pu, Z. Chen, Q. Guo, et al., Prevalence of comorbidities
in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis, Int. J. Infect. Dis. 94 (2020) 91–95,
https://doi.org/10.1016/j.ijid.[6] S. Richardson, J.S. Hirsch, M. Narasimhan, J.M. Crawford, T. McGinn,
K.W. Davidson, et al., Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area, JAMA
(2020),
https://doi.org/10.1001/jama.2020.6775.[7] D. Wang, B. Hu, C. Hu, F. Zhu, X. Liu, J. Zhang, et al., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan,
China, JAMA (2020),
https://doi.org/10.1001/jama.2020.1585.[11] P. Di Micco, V. Russo, N. Carannante, M. Imparato, S. Rodolfi, G. Cardillo,
C. Lodigiani, Clotting factors in COVID-19: epidemiological association and prog- nostic values in different clinical presentation among Italian cohort study, J Clin Med. 9 (5) (2020),
https://doi.org/10.3390/jcm9051371 pii: E1371.